Portable MRI Systems

Zynext Ventures and neuro42 Bid on Revolutionizing the Healthcare Industry

Zynext Ventures, the venture capital branch of Zydus Lifesciences, has made a strategic investment in neuro42, a company that specializes in developing portable MRI systems for neuroimaging and medical interventions. Neuro42's technology aims to bring advanced MRI capabilities directly to the patient's bedside, offering a compact and user-friendly system that can significantly expedite diagnosis and treatment. The company is also working on a robotic intervention module intended to improve procedures such as brain biopsies and ablations. While the portable MRI system has already received FDA 510(K) clearance for neuroimaging, neuro42 is seeking further regulatory approval for its interventional technology.

This investment underscores Zynext Ventures' focus on supporting disruptive innovations in the healthcare sector. By backing neuro42, Zynext Ventures is helping to accelerate the development and deployment of these novel imaging and treatment solutions, which have the potential to reshape the field of neuroimaging and surgical interventions.

Image Credit: neuro42

Portable MRI Devices
The development of portable MRI systems enables quicker diagnostics by bringing advanced imaging technology directly to the patient's bedside.
Robotic Medical Interventions
Emerging robotic modules for medical procedures promise to enhance the precision and effectiveness of treatments such as brain biopsies and ablations.
Point-of-care Imaging
Advancements in compact and user-friendly imaging systems facilitate on-site diagnostics, significantly improving patient care in various medical settings.

Sectors Adopting This

Healthcare Technology
Innovations in portable MRI systems represent a breakthrough in medical imaging, offering new capabilities and convenience.
Medical Robotics
The intersection of robotics and medical interventions is driving the evolution of more precise and minimally invasive surgical procedures.
Diagnostic Equipment
The development of accessible, high-tech diagnostic tools is transforming the landscape of medical diagnostics and treatment planning.
SCORE
4.4 out of 10
GENDER
50% Men50% Women
MARKETTop markets: North America
GENERATION
  • Gen Z
  • Gen Alpha
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 48%
Activity 53%
Freshness 32%

Solutions for innovators working at the edge of change. We help transform emerging ideas into practical, durable solutions by combining strategic thinking, creative exploration, and hands-on execution.

Trends © 2026 Trend Hunter Inc. All Rights Reserved.
LinkedIn Instagram X